Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 147

1.

FURIN Expression in Vascular Endothelial Cells Is Modulated by a Coronary Artery Disease-Associated Genetic Variant and Influences Monocyte Transendothelial Migration.

Yang X, Yang W, McVey DG, Zhao G, Hu J, Poston RN, Ren M, Willeit K, Coassin S, Willeit J, Webb TR, Samani NJ, Mayr M, Kiechl S, Ye S.

J Am Heart Assoc. 2020 Feb 18;9(4):e014333. doi: 10.1161/JAHA.119.014333. Epub 2020 Feb 11.

2.

Evaluation of A Baculovirus-Expressed VP2 Subunit Vaccine for the Protection of White-Tailed Deer (Odocoileus virginianus) from Epizootic Hemorrhagic Disease.

Sunwoo SY, Noronha LE, Morozov I, Trujillo JD, Kim IJ, Schirtzinger EE, Faburay B, Drolet BS, Urbaniak K, McVey DS, Meekins DA, Palmer MV, Balaraman V, Wilson WC, Richt JA.

Vaccines (Basel). 2020 Jan 31;8(1). pii: E59. doi: 10.3390/vaccines8010059.

3.

Immunogenicity and efficacy of Schmallenberg virus envelope glycoprotein subunit vaccines.

Endalew AD, Faburay B, Trujillo JD, Gaudreault NN, Davis AS, Shivanna V, Sunwoo SY, Ma W, Drolet BS, McVey DS, Morozov I, Wilson WC, Richt JA.

J Vet Sci. 2019 Nov;20(6):e58. doi: 10.4142/jvs.2019.20.e58.

4.

Evaluation of an Indirect Enzyme-Linked Immunosorbent Assay Based on Recombinant Baculovirus-Expressed Rift Valley Fever Virus Nucleoprotein as the Diagnostic Antigen.

Faburay B, Wilson WC, Secka A, Drolet B, McVey DS, Richt JA.

J Clin Microbiol. 2019 Sep 24;57(10). pii: e01058-19. doi: 10.1128/JCM.01058-19. Print 2019 Oct.

PMID:
31366690
5.

Understanding the survival of Zika virus in a vector interconnected sexual contact network.

Ferdousi T, Cohnstaedt LW, McVey DS, Scoglio CM.

Sci Rep. 2019 May 10;9(1):7253. doi: 10.1038/s41598-019-43651-3.

6.

EHDV-2 Infection Prevalence Varies in Culicoides sonorensis after Feeding on Infected White-Tailed Deer over the Course of Viremia.

Mendiola SY, Mills MK, Maki E, Drolet BS, Wilson WC, Berghaus R, Stallknecht DE, Breitenbach J, McVey DS, Ruder MG.

Viruses. 2019 Apr 23;11(4). pii: E371. doi: 10.3390/v11040371.

7.

Introduction of the Japanese encephalitis virus (JEV) in the United States - A qualitative risk assessment.

Oliveira ARS, Piaggio J, Cohnstaedt LW, McVey DS, Cernicchiaro N.

Transbound Emerg Dis. 2019 Jul;66(4):1558-1574. doi: 10.1111/tbed.13181. Epub 2019 Apr 16.

PMID:
30900804
8.

A spatio-temporal individual-based network framework for West Nile virus in the USA: Spreading pattern of West Nile virus.

Moon SA, Cohnstaedt LW, McVey DS, Scoglio CM.

PLoS Comput Biol. 2019 Mar 13;15(3):e1006875. doi: 10.1371/journal.pcbi.1006875. eCollection 2019 Mar.

9.

Long noncoding RNA NEXN-AS1 mitigates atherosclerosis by regulating the actin-binding protein NEXN.

Hu YW, Guo FX, Xu YJ, Li P, Lu ZF, McVey DG, Zheng L, Wang Q, Ye JH, Kang CM, Wu SG, Zhao JJ, Ma X, Yang Z, Fang FC, Qiu YR, Xu BM, Xiao L, Wu Q, Wu LM, Ding L, Webb TR, Samani NJ, Ye S.

J Clin Invest. 2019 Mar 1;129(3):1115-1128. doi: 10.1172/JCI98230. Epub 2019 Feb 4.

10.

A quantitative risk assessment (QRA) of the risk of introduction of the Japanese encephalitis virus (JEV) in the United States via infected mosquitoes transported in aircraft and cargo ships.

Oliveira ARS, Piaggio J, Cohnstaedt LW, McVey DS, Cernicchiaro N.

Prev Vet Med. 2018 Nov 15;160:1-9. doi: 10.1016/j.prevetmed.2018.09.020. Epub 2018 Sep 24.

PMID:
30388990
11.

Susceptibility of White-Tailed Deer to Rift Valley Fever Virus.

Wilson WC, Kim IJ, Trujillo JD, Sunwoo SY, Noronha LE, Urbaniak K, McVey DS, Drolet BS, Morozov I, Faburay B, Schirtzinger EE, Koopman T, Indran SV, Balaraman V, Richt JA.

Emerg Infect Dis. 2018 Sep;24(9):1717-1719. doi: 10.3201/eid2409.180265.

12.

Virological and Serological Responses of Sheep and Cattle to Experimental Schmallenberg Virus Infection.

Endalew AD, Morozov I, Davis AS, Gaudreault NN, Wernike K, Bawa B, Ruder MG, Drolet BS, McVey DS, Shivanna V, Ma W, Faburay B, Wilson WC, Richt JA.

Vector Borne Zoonotic Dis. 2018 Aug 15. doi: 10.1089/vbz.2018.2297. [Epub ahead of print]

PMID:
30109977
13.

Influence of a Coronary Artery Disease-Associated Genetic Variant on FURIN Expression and Effect of Furin on Macrophage Behavior.

Zhao G, Yang W, Wu J, Chen B, Yang X, Chen J, McVey DG, Andreadi C, Gong P, Webb TR, Samani NJ, Ye S.

Arterioscler Thromb Vasc Biol. 2018 Aug;38(8):1837-1844. doi: 10.1161/ATVBAHA.118.311030.

14.

Physiological and immunological responses to Culicoides sonorensis blood-feeding: a murine model.

Lehiy CJ, Reister-Hendricks LM, Ruder MG, McVey DS, Drolet BS.

Parasit Vectors. 2018 Jun 20;11(1):358. doi: 10.1186/s13071-018-2935-0.

15.

North American domestic pigs are susceptible to experimental infection with Japanese encephalitis virus.

Park SL, Huang YS, Lyons AC, Ayers VB, Hettenbach SM, McVey DS, Burton KR, Higgs S, Vanlandingham DL.

Sci Rep. 2018 May 21;8(1):7951. doi: 10.1038/s41598-018-26208-8.

16.

Shedding of Japanese Encephalitis Virus in Oral Fluid of Infected Swine.

Lyons AC, Huang YS, Park SL, Ayers VB, Hettenbach SM, Higgs S, McVey DS, Noronha L, Hsu WW, Vanlandingham DL.

Vector Borne Zoonotic Dis. 2018 Sep;18(9):469-474. doi: 10.1089/vbz.2018.2283. Epub 2018 May 9.

PMID:
29742002
17.

High-Polyphenol Sorghum Bran Extract Inhibits Cancer Cell Growth Through ROS Induction, Cell Cycle Arrest, and Apoptosis.

Smolensky D, Rhodes D, McVey DS, Fawver Z, Perumal R, Herald T, Noronha L.

J Med Food. 2018 Oct;21(10):990-998. doi: 10.1089/jmf.2018.0008. Epub 2018 May 7.

PMID:
29733262
18.

Assessment of data on vector and host competence for Japanese encephalitis virus: A systematic review of the literature.

Oliveira ARS, Strathe E, Etcheverry L, Cohnstaedt LW, McVey DS, Piaggio J, Cernicchiaro N.

Prev Vet Med. 2018 Jun 1;154:71-89. doi: 10.1016/j.prevetmed.2018.03.018. Epub 2018 Mar 22. Review.

PMID:
29685447
19.

Implementation of Plate Imaging for Demonstration of Monoclonality in Biologics Manufacturing Development.

Zingaro K, Shaw D, Carson J, Mayer-Bartschmid A, Bender C, Alves C, Mcvey D, Qian NX, Wei Q, Laird MW, Zhu Y, Emmins R, Follit JA, Porter A, Racher AJ, Milne S, Carubelli I, Du Z, Khatri A, Failly M, Broly H, Lee F, Reeser M, Spidel J, Anderson K, Demaria C, Di-Carlo J, Gill J, Lundquist A, Kumar SR, Gill T.

PDA J Pharm Sci Technol. 2018 Jul-Aug;72(4):438-450. doi: 10.5731/pdajpst.2018.008789. Epub 2018 Apr 18.

PMID:
29669815
20.

Evaluation of Fluorescence Microsphere Immunoassay for Detection of Antibodies to Rift Valley Fever Virus Nucleocapsid Protein and Glycoproteins.

Ragan IK, Davis AS, McVey DS, Richt JA, Rowland RR, Wilson WC.

J Clin Microbiol. 2018 May 25;56(6). pii: e01626-17. doi: 10.1128/JCM.01626-17. Print 2018 Jun.

21.

Meta-Analyses of Japanese Encephalitis Virus Infection, Dissemination, and Transmission Rates in Vectors.

Oliveira ARS, Cohnstaedt LW, Strathe E, Etcheverry L, McVey DS, Piaggio J, Cernicchiaro N.

Am J Trop Med Hyg. 2018 Mar;98(3):883-890. doi: 10.4269/ajtmh.17-0622. Epub 2018 Jan 18.

22.

Spatial multi-criteria decision analysis for modelling suitable habitats of Ornithodoros soft ticks in the Western Palearctic region.

Vial L, Ducheyne E, Filatov S, Gerilovych A, McVey DS, Sindryakova I, Morgunov S, Pérez de León AA, Kolbasov D, De Clercq EM.

Vet Parasitol. 2018 Jan 15;249:2-16. doi: 10.1016/j.vetpar.2017.10.022. Epub 2017 Nov 2.

PMID:
29279082
23.

Codon-Directed Determination of the Biological Causes of Sequence Variants in Therapeutic Proteins.

Jiang T, Song H, Slaney TR, Wu W, Langsdorf E, Gupta G, Ludwig R, Tao L, McVey D, Das TK.

Anal Chem. 2017 Dec 5;89(23):12749-12755. doi: 10.1021/acs.analchem.7b02914. Epub 2017 Nov 14.

PMID:
29086552
24.

Current Status of Rift Valley Fever Vaccine Development.

Faburay B, LaBeaud AD, McVey DS, Wilson WC, Richt JA.

Vaccines (Basel). 2017 Sep 19;5(3). pii: E29. doi: 10.3390/vaccines5030029. Review.

25.

Meta-analyses of the proportion of Japanese encephalitis virus infection in vectors and vertebrate hosts.

Oliveira ARS, Cohnstaedt LW, Strathe E, Hernández LE, McVey DS, Piaggio J, Cernicchiaro N.

Parasit Vectors. 2017 Sep 7;10(1):418. doi: 10.1186/s13071-017-2354-7. Review.

26.
27.

Multiplex Detection of IgG and IgM to Rift Valley Fever Virus Nucleoprotein, Nonstructural Proteins, and Glycoprotein in Ovine and Bovine.

Hossain MM, Wilson WC, Faburay B, Richt J, McVey DS, Rowland RR.

Vector Borne Zoonotic Dis. 2016 Aug;16(8):550-7. doi: 10.1089/vbz.2014.1721. Epub 2016 Jul 5.

PMID:
27380552
28.

Expansion of amphibian intronless interferons revises the paradigm for interferon evolution and functional diversity.

Sang Y, Liu Q, Lee J, Ma W, McVey DS, Blecha F.

Sci Rep. 2016 Jun 30;6:29072. doi: 10.1038/srep29072.

29.

A Recombinant Rift Valley Fever Virus Glycoprotein Subunit Vaccine Confers Full Protection against Rift Valley Fever Challenge in Sheep.

Faburay B, Wilson WC, Gaudreault NN, Davis AS, Shivanna V, Bawa B, Sunwoo SY, Ma W, Drolet BS, Morozov I, McVey DS, Richt JA.

Sci Rep. 2016 Jun 14;6:27719. doi: 10.1038/srep27719.

30.

The Coronary Artery Disease-associated Coding Variant in Zinc Finger C3HC-type Containing 1 (ZC3HC1) Affects Cell Cycle Regulation.

Jones PD, Kaiser MA, Ghaderi Najafabadi M, McVey DG, Beveridge AJ, Schofield CL, Samani NJ, Webb TR.

J Biol Chem. 2016 Jul 29;291(31):16318-27. doi: 10.1074/jbc.M116.734020. Epub 2016 May 19.

31.

Experimental Infection of Calves by Two Genetically-Distinct Strains of Rift Valley Fever Virus.

Wilson WC, Davis AS, Gaudreault NN, Faburay B, Trujillo JD, Shivanna V, Sunwoo SY, Balogh A, Endalew A, Ma W, Drolet BS, Ruder MG, Morozov I, McVey DS, Richt JA.

Viruses. 2016 May 23;8(5). pii: E145. doi: 10.3390/v8050145.

32.

European Bluetongue Serotype 8: Disease Threat Assessment for U.S. Sheep.

Drolet BS, Reister-Hendricks LM, Podell BK, Breitenbach JE, McVey DS, van Rijn PA, Bowen RA.

Vector Borne Zoonotic Dis. 2016 Jun;16(6):400-7. doi: 10.1089/vbz.2015.1924. Epub 2016 Apr 25.

PMID:
27111674
33.

Mosquito host choices on livestock amplifiers of Rift Valley fever virus in Kenya.

Tchouassi DP, Okiro RO, Sang R, Cohnstaedt LW, McVey DS, Torto B.

Parasit Vectors. 2016 Mar 31;9:184. doi: 10.1186/s13071-016-1473-x.

34.

A New Series of Orally Bioavailable Chemokine Receptor 9 (CCR9) Antagonists; Possible Agents for the Treatment of Inflammatory Bowel Disease.

Kalindjian SB, Kadnur SV, Hewson CA, Venkateshappa C, Juluri S, Kristam R, Kulkarni B, Mohammed Z, Saxena R, Viswanadhan VN, Aiyar J, McVey D.

J Med Chem. 2016 Apr 14;59(7):3098-111. doi: 10.1021/acs.jmedchem.5b01840. Epub 2016 Mar 17.

PMID:
26987013
35.

CHO cells knocked out for TSC2 display an improved productivity of antibodies under fed batch conditions.

McVey D, Aronov M, Rizzi G, Cowan A, Scott C, Megill J, Russell R, Tirosh B.

Biotechnol Bioeng. 2016 Sep;113(9):1942-52. doi: 10.1002/bit.25951. Epub 2016 Mar 6.

PMID:
26888596
36.

West Nile virus.

McVey DS, Wilson WC, Gay CG.

Rev Sci Tech. 2015 Aug;34(2):431-9. Review.

37.

Lesser-known bunyavirus infections.

Wilson WC, Gaudreault NN, Hossain MM, McVey DS.

Rev Sci Tech. 2015 Aug;34(2):419-29.

38.

Two Introductions of Lyme Disease into Connecticut: A Geospatial Analysis of Human Cases from 1984 to 2012.

Xue L, Scoglio C, McVey DS, Boone R, Cohnstaedt LW.

Vector Borne Zoonotic Dis. 2015 Sep;15(9):523-8. doi: 10.1089/vbz.2015.1791. Epub 2015 Sep 8.

PMID:
26348105
39.

Vaccines for Prevention of Bluetongue and Epizootic Hemorrhagic Disease in Livestock: A North American Perspective.

McVey DS, MacLachlan NJ.

Vector Borne Zoonotic Dis. 2015 Jun;15(6):385-96. doi: 10.1089/vbz.2014.1698. Review.

PMID:
26086559
40.

Orbiviruses: A North American Perspective.

McVey DS, Drolet BS, Ruder MG, Wilson WC, Nayduch D, Pfannenstiel R, Cohnstaedt LW, MacLachlan NJ, Gay CG.

Vector Borne Zoonotic Dis. 2015 Jun;15(6):335-8. doi: 10.1089/vbz.2014.1699.

PMID:
26086554
41.

A glycoprotein subunit vaccine elicits a strong Rift Valley fever virus neutralizing antibody response in sheep.

Faburay B, Lebedev M, McVey DS, Wilson W, Morozov I, Young A, Richt JA.

Vector Borne Zoonotic Dis. 2014 Oct;14(10):746-56. doi: 10.1089/vbz.2014.1650.

42.

'By failing to prepare you are preparing to fail': lessons from the 2009 H1N1 'swine flu' pandemic.

Crosier A, McVey D, French J.

Eur J Public Health. 2015 Feb;25(1):135-9. doi: 10.1093/eurpub/cku131. Epub 2014 Aug 14.

PMID:
25125575
43.

Evaluation of lamb and calf responses to Rift Valley fever MP-12 vaccination.

Wilson WC, Bawa B, Drolet BS, Lehiy C, Faburay B, Jasperson DC, Reister L, Gaudreault NN, Carlson J, Ma W, Morozov I, McVey DS, Richt JA.

Vet Microbiol. 2014 Aug 6;172(1-2):44-50. doi: 10.1016/j.vetmic.2014.04.007. Epub 2014 Apr 18.

PMID:
24856133
44.

Complete Closed Genome Sequences of Three Bibersteinia trehalosi Nasopharyngeal Isolates from Cattle with Shipping Fever.

Harhay GP, McVey DS, Koren S, Phillippy AM, Bono J, Harhay DM, Clawson ML, Heaton MP, Chitko-McKown CG, Korlach J, Smith TP.

Genome Announc. 2014 Feb 13;2(1). pii: e00084-14. doi: 10.1128/genomeA.00084-14.

45.

Distinct patterns of health engagement among adolescents and young adults in England: implications for health services.

Hargreaves DS, James D, Goddings AL, McVey D, Viner RM.

Perspect Public Health. 2014 Mar;134(2):81-4. doi: 10.1177/1757913913519770. Epub 2014 Feb 6.

PMID:
24503917
46.

Rift Valley fever virus structural and nonstructural proteins: recombinant protein expression and immunoreactivity against antisera from sheep.

Faburay B, Wilson W, McVey DS, Drolet BS, Weingartl H, Madden D, Young A, Ma W, Richt JA.

Vector Borne Zoonotic Dis. 2013 Sep;13(9):619-29. doi: 10.1089/vbz.2012.1285. Epub 2013 Aug 20.

47.

Identification of a suppressor mutation that improves the yields of hexon-modified adenovirus vectors.

Bruder JT, Chen P, Semenova E, Thomas CA, Konovalova S, Ekberg G, Ettyreddy D, McVey D, Gall JG, King CR, Brough DE.

J Virol. 2013 Sep;87(17):9661-71. doi: 10.1128/JVI.00462-13. Epub 2013 Jul 3.

48.

Automated design of paralogue ratio test assays for the accurate and rapid typing of copy number variation.

Veal CD, Xu H, Reekie K, Free R, Hardwick RJ, McVey D, Brookes AJ, Hollox EJ, Talbot CJ.

Bioinformatics. 2013 Aug 15;29(16):1997-2003. doi: 10.1093/bioinformatics/btt330. Epub 2013 Jun 6.

49.

Safety and efficacy of ulimorelin administered postoperatively to accelerate recovery of gastrointestinal motility following partial bowel resection: results of two randomized, placebo-controlled phase 3 trials.

Shaw M, Pediconi C, McVey D, Mondou E, Quinn J, Chamblin B, Rousseau F.

Dis Colon Rectum. 2013 Jul;56(7):888-97. doi: 10.1097/DCR.0b013e31829196d0.

PMID:
23739196
50.

Diagnostic approaches for Rift Valley fever.

Wilson WC, Weingartl HM, Drolet BS, Davé K, Harpster MH, Johnson PA, Faburay B, Ruder MG, Richt JA, McVey DS.

Dev Biol (Basel). 2013;135:73-8. doi: 10.1159/000276828. Epub 2013 May 14.

PMID:
23689885

Supplemental Content

Support Center